Cargando…

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods

On-demand therapies for Parkinson’s disease (PD) provide rapid, reliable relief for patients experiencing OFF periods; however, practical guidelines on the use of these therapies are not generally available. This paper reviews the use of on-demand treatments. Motor fluctuations occur in nearly all p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pahwa, Rajesh, Pagan, Fernando L., Kremens, Daniel E., Saint-Hilaire, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310675/ https://www.ncbi.nlm.nih.gov/pubmed/37221354 http://dx.doi.org/10.1007/s40120-023-00486-5

Ejemplares similares

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Pupillary Response to Postural Demand in Parkinson’s Disease
por: Kahya, Melike, et al.
Publicado: (2021)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease
por: Martinez-Nunez, Alfonso E., et al.
Publicado: (2023)

Pupillary Response to Cognitive Demand in Parkinson’s Disease: A Pilot Study
por: Kahya, Melike, et al.
Publicado: (2018)

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos, Fabiane, et al.
Publicado: (2015)

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
por: Pahwa, Rajesh, et al.
Publicado: (2023)

Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease
por: Lew, Mark, et al.
Publicado: (2017)

Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods?
por: Luinstra, M., et al.
Publicado: (2015)

Use of Figurative Language by People With Parkinson Disease to Describe “Off” Periods: Clear as Mud
por: Chahine, Lana M., et al.
Publicado: (2021)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
por: Kremens, Daniel, et al.
Publicado: (2017)

Mapping spontaneous facial expression in people with Parkinson’s disease: A multiple case study design
por: Gunnery, Sarah D., et al.
Publicado: (2017)

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022)

A review of ropinirole prolonged release in Parkinson’s disease
por: Nashatizadeh, Muhammad M, et al.
Publicado: (2009)

Communication About OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners
por: Rastgardani, Tara, et al.
Publicado: (2019)

Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®
por: Pahwa, Rajesh, et al.
Publicado: (2020)

The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
por: Antonini, Angelo, et al.
Publicado: (2021)

Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease
por: Gupta, Fiona, et al.
Publicado: (2017)

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
por: Antonini, Angelo, et al.
Publicado: (2022)

Capturing Initial Understanding and Impressions of Surgical Therapy for Parkinson's Disease
por: Das, Somnath, et al.
Publicado: (2021)

The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartners
por: Armstrong, Melissa J., et al.
Publicado: (2019)

Erratum to: Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease
por: Gupta, Fiona, et al.
Publicado: (2017)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
por: Sharma, Vibhash D, et al.
Publicado: (2018)

Association of Cumulative Lead Exposure with Parkinson’s Disease
por: Weisskopf, Marc G., et al.
Publicado: (2010)

Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease
por: Hanna-Pladdy, Brenda, et al.
Publicado: (2013)

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study
por: Kassubek, Jan, et al.
Publicado: (2023)

Management of OFF condition in Parkinson disease
por: Koch, Jessa
Publicado: (2023)

Assessing last-mile distribution resilience under demand disruptions
por: Pahwa, Anmol, et al.
Publicado: (2023)

Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews
por: Armstrong, Melissa J., et al.
Publicado: (2019)

Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia
por: Hauser, Robert A., et al.
Publicado: (2021)

Sialorrhea in Parkinson’s Disease
por: Isaacson, Jonathan, et al.
Publicado: (2020)

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson’s Disease
por: Brillman, Salima, et al.
Publicado: (2023)

QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review
por: Torres-Yaghi, Yasar, et al.
Publicado: (2021)

Non-Motor Off Symptoms in Parkinson's Disease
por: Cheon, Sang-Myung, et al.
Publicado: (2009)

Off-time Treatment Options for Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2023)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3320o610qcknrkjhvau8f6etbb